Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Merck & Co., Inc.
  6. News
  7. Summary
    MRK   US58933Y1055

MERCK & CO., INC.

(MRK)
  Report
Real-time Estimate Cboe BZX  -  05/16 10:26:54 am EDT
91.31 USD   +1.00%
02:10aRising Cyber Attacks Could Make Insurance Unaffordable
AQ
05/13Tesla, Occidental rise; New Relic, Merck fall
AQ
05/12Thinking about trading options or stock in Hess, Electronic Arts, Merck, Microsoft, or General Electric?
PR
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck Completes Acceleron Pharma Acquisition

11/22/2021 | 06:54am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
MERCK & CO., INC. 0.51% 90.84 Delayed Quote.17.97%
NASDAQ COMP. -0.38% 11753.23 Real-time Quote.-24.54%
All news about MERCK & CO., INC.
02:10aRising Cyber Attacks Could Make Insurance Unaffordable
AQ
05/13Tesla, Occidental rise; New Relic, Merck fall
AQ
05/12Thinking about trading options or stock in Hess, Electronic Arts, Merck, Microsoft, or ..
PR
05/11TRANSCRIPT : Merck & Co., Inc. Presents at Bank of America 2022 Healthcare Conference, May..
CI
05/10SECTOR UPDATE : Health Care Stocks Still Edging Higher This Afternoon
MT
05/10Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medic..
BU
05/10Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medic..
CI
05/05MERCK & CO., INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/05Nabriva Therapeutics Signs Extended Deal With Merck to Promote, Distribute Sivextro Thr..
MT
05/05Nabriva Extends Exclusive Agreement to Promote and Distribute Sivextro® (Tedizolid Phos..
CI
More news
Analyst Recommendations on MERCK & CO., INC.
More recommendations
Financials (USD)
Sales 2022 57 853 M - -
Net income 2022 15 590 M - -
Net Debt 2022 16 498 M - -
P/E ratio 2022 14,7x
Yield 2022 3,08%
Capitalization 229 B 229 B -
EV / Sales 2022 4,24x
EV / Sales 2023 4,15x
Nbr of Employees 67 500
Free-Float 70,6%
Chart MERCK & CO., INC.
Duration : Period :
Merck & Co., Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK & CO., INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 90,41 $
Average target price 95,19 $
Spread / Average Target 5,29%
EPS Revisions
Managers and Directors
Robert M. Davis President, Chief Executive Officer & Director
Caroline A. Litchfield Chief Financial Officer & Executive Vice President
Kenneth C. Frazier Executive Chairman
Dave Williams EVP, Chief Information & Digital Officer
Lisa LeCointe-Cephas Chief Ethics & Compliance Officer, SVP
Sector and Competitors
1st jan.Capi. (M$)
MERCK & CO., INC.17.97%228 629
JOHNSON & JOHNSON3.38%465 363
PFIZER, INC.-15.46%280 096
ABBVIE INC.13.37%271 251
ELI LILLY AND COMPANY5.58%262 514
ROCHE HOLDING AG-15.85%258 421